Insights

Regenerative Medicine Fraunhofer IZI specializes in regenerative medicine with core competencies in oncology, ischemia, and autoimmune/inflammatory diseases, presenting multiple collaboration avenues for contract research, product development, and GMP-compliant manufacturing of investigational medicinal products.

GMP and Compliance The institute offers GMP-compliant manufacture and quality checks, plus support in obtaining manufacturing authorizations and approvals, signaling opportunities to partner for regulated development, scale-up, and regulatory readiness for biotechnological therapeutics.

Contract Research As a contract research organization serving biotechnological, pharmaceutical, medical-tech firms and hospitals, Fraunhofer IZI can provide method optimization, validation, and material/product development across cell therapy, diagnostics, and biobanking units.

Tech Enablement Leveraging a diverse tech stack including Power Platform, Docker, GitLab, and DocuSign, there are opportunities to offer digital workflow optimization, data management, and secure e-signature solutions to streamline research operations and compliance.

Strategic Partnerships Recent Fraunhofer ICT Group initiatives and spin-offs in wastewater analytics, sensor systems, and energy-related diagnostics indicate a collaborative ecosystem with cross-domain innovation, ideal for joint ventures, technology licensing, or co-development programs.

Similar companies to Fraunhofer IZI

Fraunhofer IZI Tech Stack

Fraunhofer IZI uses 8 technology products and services including Microsoft Power Platform, Ansible, Docker, and more. Explore Fraunhofer IZI's tech stack below.

Media & News

Fraunhofer IZI's Email Address Formats

Fraunhofer IZI uses at least 5 email formats:
Fraunhofer IZI Email FormatsExamplePercentage
First.Last@izi.fraunhofer.deJohn.Doe@izi.fraunhofer.de
98%
Last.First@izi.fraunhofer.deDoe.John@izi.fraunhofer.de
2%
First.Last@fraunhofer.deJohn.Doe@fraunhofer.de
92%
First@fraunhofer.deJohn@fraunhofer.de
7%
FLast@fraunhofer.deJDoe@fraunhofer.de
1%

Frequently Asked Questions

What is Fraunhofer IZI's official website and social media links?

Minus sign iconPlus sign icon
Fraunhofer IZI's official website is fraunhofer.de and has social profiles on LinkedIn.

How much revenue does Fraunhofer IZI generate?

Minus sign iconPlus sign icon
As of August 2026, Fraunhofer IZI's annual revenue is estimated to be $10M - $25M.

What is Fraunhofer IZI's SIC code and NAICS code?

Minus sign iconPlus sign icon
Fraunhofer IZI's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fraunhofer IZI have currently?

Minus sign iconPlus sign icon
As of August 2026, Fraunhofer IZI has approximately 273 employees across 3 continents, including Europe, Asia and North America. Key team members include Head Of Department Of Medical Bioinformatics: K. R., Head Of Department "gmp Cell And Gene Therapy": G. S. and Head Of Diagnostics Department: D. K. Explore Fraunhofer IZI's employee directory with LeadIQ.

What industry does Fraunhofer IZI belong to?

Minus sign iconPlus sign icon
Fraunhofer IZI operates in the Biotechnology Research industry.

What technology does Fraunhofer IZI use?

Minus sign iconPlus sign icon
Fraunhofer IZI's tech stack includes Microsoft Power Platform, Ansible, Docker, WordPress, Adobe Experience Cloud, Microsoft Active Directory, GitLab and DocuSign.

What is Fraunhofer IZI's email format?

Minus sign iconPlus sign icon
Fraunhofer IZI's email format typically follows the pattern of First.Last@izi.fraunhofer.de. Find more Fraunhofer IZI email formats with LeadIQ.

When was Fraunhofer IZI founded?

Minus sign iconPlus sign icon
Fraunhofer IZI was founded in 2005.
Fraunhofer IZI logo

Fraunhofer IZI

Biotechnology ResearchSaxony, Germany201-500 Employees

The Fraunhofer Institute for Cell Therapy and Immunology IZI conducts applied research at the interfaces of medicine, life sciences, and engineering. It provides contract research services to biotechnological, pharmaceutical and medical-technology companies, hospitals, diagnostic laboratories and research facilities, developing, optimizing and validating methods, materials and products within its business units, including Agents, Cell Therapy, and Diagnostic and Biobanking. Its core strengths lie in regenerative medicine, with focus areas in oncology, ischemia, and autoimmune, inflammatory and infectious diseases. The institute takes a clinically oriented approach, performing quality checks and GMP-compliant manufacture of investigational medicinal products, and offering support to obtain manufacturing authorizations and approvals. Based in Leipzig, Saxony, Germany, it is a mid-sized organization employing several hundred people.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
201-500

Section iconFunding & Financials

  • $10M - $25M

    Fraunhofer IZI's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.